Phagocytes— these are macrophages, neutrophils, dendritic cells (DCs), monocytes and a handful of “special teams” such as eosinophils and Langerhans cells—constitute the professional ingesters of the immune repertoire. They provide (i) first-contact host defence, (ii) orchestration of downstream adaptive immunity, and (iii) cleanup and repair after inflammation. They are therefore both sentinels and governors of immune homeostasis.
IL-6/STAT3 and G-CSF force granulocytic bias and accelerate cell-cycle kinetics (6-fold output in <48 h) during sepsis or chemotherapy-induced cytopenia
Common dendritic-cell progenitor (CDP)
FLT3L → pre-cDC → cDC1 / cDC2; TCF4 → pDC
BATF3 (cDC1), IRF4 (cDC2)
IFN-I drive “emergency DC-poiesis” that favours pDC expansion in viral infection
Clinical pearl – Exaggerated emergency myelopoiesis underlies paraneoplastic neutrophilia and the myeloid-derived suppressor cell (MDSC) surge that blunts antitumour immunity.
3 Molecular Mechanics of Phagocytosis
Recognition (the “zipper” phase)
Opsonic receptors—FcγR, CR1/3—bind IgG and C3 fragments; non-opsonic PRRs such as Dectin-1 and MARCO detect β-glucan and bacterial lipids.
Engulfment & Actin remodellingITAM→Syk→PI3K→Rac/WAVE drives a cup-shaped F-actin collar; catch-bond mechanics ensure only high-avidity targets are taken up.
Phagosome maturationRab5→Rab7 exchange, V-ATPase acidification (pH ≈ 5), and TMEM206/ASOR proton-activated Cl⁻ channelsdissipate charge to sustain the H⁺ gradient .
Microbicidal modulesNADPH-oxidase → O₂•⁻ → H₂O₂ / HOCl; iNOS produces NO• that combines with superoxide to form peroxynitrite; cathepsins, lysozyme and metal intoxication (Zn²⁺ burst) complete the kill.
4 Macrophages
Resident vs. monocyte-derived Microglia, Kupffer, and alveolar macrophages are yolk-sac/fetal-liver derivatives with self-renewal; inflammation recruits CCR2⁺ Ly6Cᵗᵐᵉʳʳᵧ⁺ monocytes that differentiate in situ.
Activation spectrum Single-cell RNA-seq reveals a continuum rather than M1/M2 binaries, with NF-κB-driven “early inflammatory”, STAT6/PPARγ “pro-resolving” and TREM2⁺ fibrosis-associated states .
Metabolic rewiring Inflammatory macrophages rely on aerobic glycolysis and itaconate synthesis; reparative macrophages re-establish mitochondrial fusion and β-oxidation.
Cancer CSF1R-dependent tumour-associated macrophages (TAMs) suppress cytotoxic T cells; durable CSF1R blockade reprograms TAMs and synergises with checkpoint inhibitors .
5 Neutrophils
Theme
Details
Clinical correlation
Heterogeneity
Maturing neutrophils acquire granule strata (primary–tertiary) and transcriptional subsets such as pro-angiogenic, PMN-MDSC and interferon-programmed cells
Failure of wave shutdown in chronic granulomatous disease (CGD) causes uncontrolled neutrophil clustering
NETosis
PAD4-mediated histone citrullination expels chromatin webs; serves antimicrobial trapping but also catalyses immunothrombosis
Excess NETs foster deep-vein thrombosis and fuel cancer metastasis
Primary deficiency spotlight – CGD (NOX2 mutations) presents with recurrent catalase-positive infections and granuloma formation; prophylactic TMP-SMX + itraconazole and IFN-γ injections reduce mortality .
6 Dendritic Cells
Subset overview
cDC1 (XCR1⁺, BATF3/IRF8)—specialists in cross-presenting viral and tumour antigens.
cDC2 (CD172a⁺, IRF4)—flexible instructors of Th2/Th17 immunity; recent work shows functional micro-clusters within cDC2 distinguished by Notch and KLF4 activity .
pDC (TCF4⁺)—high-capacity type-I IFN producers in antiviral states.
mo-DC & Langerhans cells—inflammatory or barrier-resident variants; Langerhans dendrites cross tight junctions to sample surface antigens without breaching epidermal integrity .
Clinical translation Genetic “re-wiring” of tumour cells with BATF3/IRF8/PU.1 converts them into cDC1-like antigen presenters, yielding potent in-situ cancer vaccines in murine models .
7 Other Phagocytic Specialists
Cell
Niche function
Pathology when dysregulated
Monocytes (Ly6C⁺/⁻)
Intravascular patrol, rapid tissue seeding
Monocytosis predicts cardiovascular risk
Eosinophils & basophils
FcεRI-mediated phagocytosis of opsonised parasites; granule toxin release
Allergy, hypereosinophilic syndromes
Mast cells
Perivascular sentinels—phagocytose nanoparticles and secrete pre-formed mediators
Anaphylaxis, mastocytosis
8 Cross-Talk Circuits
Neutrophil→Macrophage Aged CXCR4^hi neutrophils transmigrate back to marrow, delivering S100A8/A9 that amplifies G-CSF and emergency myelopoiesis .
Macrophage/DC→T cell IL-12 from cDC1 licenses cytotoxic T lymphocytes; PD-L1⁺ macrophages induce T-cell exhaustion in tumours.
Phagocyte-stromal Scar-associated TREM2⁺ macrophages instruct PDGFRβ⁺ fibroblasts to deposit collagen; stromal IL-33 feeds back to sustain macrophage survival.
9 Therapeutic & Diagnostic Frontiers
Strategy
Mechanism
Development stage
CSF1R inhibitors (e.g., BLZ945)
Deplete or re-educate TAMs
Phase II trials in glioma & breast CA
PAD4 or DNase I blockers
Limit deleterious NETosis
Pre-clinical thrombosis models
TREM2 antagonists
Reduce fibrosis-driving macrophages
Pre-clinical IPF mouse data
In-vivo DC reprogramming (IRF8/BATF3 gene transfer)
Convert tumour cells into professional APCs
Proof-of-concept in mice
10 Summary
Lineage—All professional phagocytes originate from myeloid progenitors but diverge early via distinct transcription factors and tissue imprinting.
Function depends on context—Macrophage and neutrophil phenotypes are plastic, governed by cytokines, metabolites and mechanical cues.
Defects matter clinically—From CGD to cancer-associated immunosuppression, phagocyte dysfunction has direct diagnostic and therapeutic implications.
Therapies are here—Targeting phagocytes (CSF1R, TREM2, NETosis) is an expanding frontier in oncology, fibrosis and thrombosis.
Lifelong learning—Emerging single-cell and spatial ‘omics will continue to refine phagocyte taxonomy and open new intervention windows.
References
Brown, L., & Yipp, B. G. (2023). Neutrophil swarming: Is a good offense the best defense?iScience, 26(9), 107655. https://doi.org/10.1016/j.isci.2023.107655
Cui, H., Banerjee, S., Xie, N., et al. (2025). TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity.Nature Communications, 16, 1761. https://doi.org/10.1038/s41467-025-57024-0
Frontiers Immunology Editorial Board. (2024). Dendritic cell subsets and implications for cancer immunotherapy.Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1393451
Mayo Clinic Staff. (2025). Chronic granulomatous disease: Diagnosis and treatment. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/chronic-granulomatous-disease/
Sato, T., Sugiyama, D., Koseki, J., et al. (2025). Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages.JCI Insight, 10(1), e178146. https://doi.org/10.1172/jci.insight.178146
Swann, J. W., Olson, O. C., & Passegué, E. (2024). Made to order: Emergency myelopoiesis and demand-adapted innate immune cell production.Nature Reviews Immunology, 24(8), 596-613. https://doi.org/10.1038/s41577-024-00998-7
Wang, H., Kim, S. J., Lei, Y., & Tsung, A. (2024). Neutrophil extracellular traps in homeostasis and disease.Signal Transduction and Targeted Therapy, 9, 235. https://doi.org/10.1038/s41392-024-01933-x
Yamada, R., & colleagues. (2024). Proton-gated anion transport governs macropinosome shrinkage via TMEM206.Nature Cell Biology. Advance online publication. https://pubmed.ncbi.nlm.nih.gov/ (Article ID PMCID: PMC9203271)
Yeo, C., et al. (2024). Exploring neutrophil heterogeneity and plasticity in health and disease.Clinical & Molecular Immunology Review 17, 45-68. https://doi.org/10.1002/mco2.70063
Zhang, L., Ascic, E., & Pereira, C.-F. (2024). In-vivo dendritic-cell reprogramming for cancer immunotherapy.Science, 386, eadn9083. https://doi.org/10.1126/science.adn9083
